ESR1 and breast carcinoma: Nearly all breast cancer tissues expressed estrogen receptor (ER, 90.5% of samples) and progesterone receptor (PR, 70% of samples), meaning that luminal molecular subtype (91.6%) prevailed in evaluated samples.